Apr 20, 2016
9:5
For every 5 shares held, investors received 9. The price per share adjusted from $15.85 to $8.81.
The split itself did not change the total investment value.
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Class A (SZSE:300255) operates in the Biotechnology industry.
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Class A company overviewHebei Changshan Biochemical Pharmaceutical Co., Ltd. Class A's most recent stock split was on April 20, 2016. It was a 9-for-5 forward split, so shareholders received 9 shares for every 5 they held.
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Class A (SZSE:300255) has split its stock 3 times: a 17-for-10 split on July 10, 2012, a 5-for-2 split on April 30, 2015, and a 9-for-5 split on April 20, 2016.
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Class A has split its stock 3 times. This history records 3 forward splits between July 10, 2012 and April 20, 2016.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Class A's 9-for-5 split on April 20, 2016, every 5 shares became 9 shares.
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on April 20, 2016, 10 years ago. Companies announce splits in advance, and any new SZSE:300255 split will appear on this page.
Already premium?